Magle Chemoswed Holding AB (FRA:52X) FFO


FRA:52X Magle Chemoswed Holding AB FRA:52X
40 GF Score
Price €0.08
GF Value €1.79
! 6 Warning Signs
View Full Analysis

What is Magle Chemoswed Holding AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:52X
40GF Score
Magle Chemoswed Holding AB FRA:52X
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Magle Chemoswed Holding AB (FRA:52X) Overvalued in 2026?

Based on GuruFocus' analysis, Magle Chemoswed Holding AB stock appears to be undervalued. The current stock price of €0.08 is trading 95.5% below its estimated GF Value™ of €1.79.

Key valuation signals for FRA:52X:

  • FFO:
  • GF Value™: €1.79 vs. price of €0.08 (95.5% below fair value)
  • GF Score™: 40/100 with 6 warning signs

No single metric tells the full story. See the FRA:52X stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Magle Chemoswed Holding AB Business Description

Other Exchanges MAGLE:Sweden52X:Germany
Address Agneslundsvagen 27, Malmo, SWE, 21215
Magle Chemoswed Holding AB is a contract development and manufacturing organization that serves companies in the pharmaceutical and medical device industry on a contract basis. It provides comprehensive services from product development through product manufacturing. The company's products portfolio includes Warfarin sodium, Melperone hydrochloride, Isradipine, Amantadine sulfate, and Benserazide hydrochloride.
40GF Score

Get the complete analysis for FRA:52X

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.08
Price
€1.79
GF Value